Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Vitrolife

Market Cap: SEK 17.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Hansa Biopharma

Market Cap: SEK 3.3b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Vicore Pharma Holding

Market Cap: SEK 3.1b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Egetis Therapeutics

Market Cap: SEK 2.0b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Saniona

Market Cap: SEK 1.6b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Diamyd Medical

Market Cap: SEK 1.6b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

BICO Group

Market Cap: SEK 1.4b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Cinclus Pharma Holding

Market Cap: SEK 813.5m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

Xbrane Biopharma

Market Cap: SEK 671.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Cantargia

Market Cap: SEK 635.2m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

FluoGuide

Market Cap: SEK 533.9m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Guard Therapeutics International

Market Cap: SEK 441.7m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Ascelia Pharma

Market Cap: SEK 394.5m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Magle Chemoswed Holding

Market Cap: SEK 384.1m

Engages in research and development of pharmaceutical and medical device products in Sweden.

Intervacc

Market Cap: SEK 354.4m

Develops novel veterinary vaccines for animals in Sweden.

Curasight

Market Cap: DKK 232.1m

Develops therapeutic and diagnostic solutions for the treatment of cancer.

Mendus

Market Cap: SEK 339.9m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

AlzeCure Pharma

Market Cap: SEK 296.5m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

IRLAB Therapeutics

Market Cap: SEK 248.0m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

Karolinska Development

Market Cap: SEK 245.5m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Lipum

Market Cap: SEK 242.9m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.

Initiator Pharma

Market Cap: SEK 232.7m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Isofol Medical

Market Cap: SEK 224.9m

Operates as a clinical stage biotech company.

Active Biotech

Market Cap: SEK 199.0m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Annexin Pharmaceuticals

Market Cap: SEK 197.7m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Medivir

Market Cap: SEK 179.5m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Biovica International

Market Cap: SEK 169.0m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Alligator Bioscience

Market Cap: SEK 160.1m

A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 124.0m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

Vivesto

Market Cap: SEK 122.7m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

Biosergen

Market Cap: SEK 121.6m

A biotech company, develops antifungal products.

Alzinova

Market Cap: SEK 117.1m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

NextCell Pharma

Market Cap: SEK 105.8m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

Nanologica

Market Cap: SEK 101.6m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.